Struck et al. (2022) High seroprevalence of SARS-CoV-2 in Burkina Faso, Ghana and Madagascar in 2021.pdf (1.24 MB)
High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study
journal contribution
posted on 2023-06-10, 04:40 authored by Nicole S Struck, Eva Lorenz, Christina Deschermeier, Daniel Eibach, Jenny Kettenbeil, Wibke Loag, Steven BriegerSteven Brieger, Anna M Ginsbach, Christian Obirikorang, Oumou Maiga-Ascofare, Yaw Adu Sarkodie, Eric Ebenezer Amprofi Boham, Evans Asamoah Adu, Gracelyn Asare, Amos Amoako-Adusei, othersBackground The current COVID-19 pandemic affects the entire world population and has serious health, economic and social consequences. Assessing the prevalence of COVID-19 through population-based serological surveys is essential to monitor the progression of the epidemic, especially in African countries where the extent of SARS-CoV-2 spread remains unclear. Methods A two-stage cluster population-based SARS-CoV-2 seroprevalence survey was conducted in Bobo-Dioulasso and in Ouagadougou, Burkina Faso, Fianarantsoa, Madagascar and Kumasi, Ghana between February and June 2021. IgG seropositivity was determined in 2,163 households with a specificity improved SARS-CoV-2 Enzyme-linked Immunosorbent Assay. Population seroprevalence was evaluated using a Bayesian logistic regression model that accounted for test performance and age, sex and neighbourhood of the participants. Results Seroprevalence adjusted for test performance and population characteristics were 55.7% [95% Credible Interval (CrI) 49·0; 62·8] in Bobo-Dioulasso, 37·4% [95% CrI 31·3; 43·5] in Ouagadougou, 41·5% [95% CrI 36·5; 47·2] in Fianarantsoa, and 41·2% [95% CrI 34·5; 49·0] in Kumasi. Within the study population, less than 6% of participants performed a test for acute SARS-CoV-2 infection since the onset of the pandemic. Conclusions High exposure to SARS-CoV-2 was found in the surveyed regions albeit below the herd immunity threshold and with a low rate of previous testing for acute infections. Despite the high seroprevalence in our study population, the duration of protection from naturally acquired immunity remains unclear and new virus variants continue to emerge. This highlights the importance of vaccine deployment and continued preventive measures to protect the population at risk.
History
Publication status
- Published
File Version
- Published version
Journal
BMC Public HealthISSN
1471-2458Publisher
Springer Science and Business Media LLCExternal DOI
Volume
22Page range
a1617 1-9Department affiliated with
- Strategy and Marketing Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2022-09-07First Open Access (FOA) Date
2022-09-07First Compliant Deposit (FCD) Date
2022-09-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC